SEA 2022 Standards for Global Control of Cardiovascular Risk
Jose Maria Mostaza 1 , Xavier Pintó 2 , Pedro Armario 3 , Luis Masana 4 , José T Real 5 , Pedro Valdivielso 6 , Teresa Arrobas-Velilla 7 , Ramón Baeza-Trinidad 8 , Pilar Calmarza 9 , Jesús Cebollada 10 , M Civera-Andrés 11 , J I Cuende Melero 12 , J L Díaz-Díaz 13 , J Fernández Pardo 14 , C Guijarro 15 , C Jericó 3 , M Laclaustra 16 , C Lahoz 17 , J López-Miranda 18 , S Martínez-Hervás 5 , O Muñiz-Grijalvo 19 , J A Páramo 20 , V Pascual 21 , J Pedro-Botet 22 , P Pérez-Martínez 18 , N Plana 4 , J Puzo 23 , M Á Sánchez Chaparro 24 , L Vila
One of the objectives of the Spanish Society of Arteriosclerosis is to contribute to better knowledge of vascular disease, its prevention and treatment. It is well known that cardiovascular diseases are the leading cause of death in our country and entail a high degree of disability and health care costs.
Arteriosclerosis is a multifactorial disease and therefore its prevention requires a global approach that takes into account the different risk factors with which it is associated. Therefore, this document summarizes the current level of knowledge and includes recommendations and procedures to be followed in patients with established cardiovascular disease or at high vascular risk.
Specifically, this document reviews the main symptoms and signs to be evaluated during the clinical visit, the laboratory and imaging procedures to be routinely requested or requested for those in special situations. It also includes vascular risk estimation, the diagnostic criteria of the different entities that are cardiovascular risk factors, and makes general and specific recommendations for the treatment of the different cardiovascular risk factors and their final objectives.
Finally, the document includes aspects that are not usually referenced in the literature, such as the organization of a vascular risk consultation.
CITA DEL ARTÍCULO Clin Investig Arterioscler. May-Jun 2022;34(3):130-179. doi: 10.1016/j.arteri.2021.11.003. Epub 2022 Jan 25.